Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9321831 RSV-specific binding molecules and means for producing them

Patent 9321831 was granted and assigned to Medimmune Limited on April, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 3 Jul, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 3 Jul, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12024553 Dosage regimens for and compositions including anti-RSV antibodies
0
Edits on 5 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 5 Dec, 2023
Edits made to:
Article (+172 characters)
Article

Patent abstract

The invention provides antibodies and functional equivalents thereof which are capable of specifically binding RSV, and means and methods for producing them.

Edits on 29 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 29 Sep, 2023
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Etsuko Yasuda0
Hergen Spits0
Mark Jeroen Kwakkenbos0
Tim Beaumont0
Edits on 21 Jul, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 21 Jul, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=09321831
Edits on 7 Jun, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Jun, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11667698 Anti-RSV monoclonal antibody formulation
0
Edits on 31 May, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 31 May, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11661449 RSV-specific antibodies and functional parts thereof
0
Edits on 24 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 24 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 09321831 RSV-specific binding molecules and means for producing them US Patent 9321831 RSV-specific binding molecules and means for producing them

Infobox
Patent Number
09321831
Patent Number
9321831
Edits on 17 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 17 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=09321831
Edits on 6 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 6 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 09321831 RSV-specific binding molecules and means for producing them

Infobox
Is a
Patent
Patent
Patent applicant
Current assignee
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
09321831
Date of patent
April 26, 2016
Patent application number
14026182
Date Filed
September 13, 2013
Patent primary examiner
‌
Stacy B. Chen

Find more entities like US Patent 9321831 RSV-specific binding molecules and means for producing them

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.